Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Fujifilm Launches ColoAssist PRO, a Real-time Endoscope Visualisation System Which Aims to Help Endoscopists Perform Efficient, Accurate and Comfortable Colonoscopies
Fujifilm has launched ColoAssist PRO, a real-time endoscope visualisation system, designed to assist endoscopists in […]
Robocath Successfully Performs First Carotid Stenting in France with R-One™ Robot at Rennes University Hospital
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of […]
Trodelvy ® (sacituzumab govitecan) Granted European Commission Marketing Authorization for Treatment of Metastatic Triple-Negative Breast Cancer in Second Line
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted marketing […]
Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment […]
LoQus23 Therapeutics Exits Stealth with £11.5 Million Seed Financing from the Dementia Discovery Fund and Novartis Venture Fund
LoQus23 Therapeutics Ltd. (‘LoQus23’), a company discovering small molecule therapies that target aberrant DNA mismatch […]
Main Street Radiology Adopts Agamon's AI-Engine to Boost Follow-Ups Automatically
Medical imaging services provider Main Street Radiology (MSR) is building stronger relationships with referring physicians […]
AstraZeneca Unveils The Discovery Centre (DISC) in Cambridge
AstraZeneca will today, in the presence of His Royal Highness The Prince of Wales, formally […]
Caixa Capital Risc Leads Sale of Sanifit Therapeutics to Vifor Pharma with Upfront Payment of €205M
Caixa Capital Risc, the venture capital subsidiary of CriteriaCaixa, today announces the sale of its […]
Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutant Non-Small Cell Lung Cancer
Mirati Therapeutics, Inc. (Nasdaq:MRTX), a clinical-stage targeted oncology company and Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to […]
Neurocrine Biosciences and Sosei Heptares Announce Collaboration to Develop Novel Muscarinic Receptor Agonists for Schizophrenia and Other Neuropsychiatric Disorders
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Sosei Group Corporation (“Sosei Heptares“; TSE: 4565) announce the signing […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more